Join the club for FREE to access the whole archive and other member benefits.

Apollo Ventures

Venture capital firm investing in seed and early stage biotechnology companies

Apollo Health Ventures is an Early Stage Investment Firm interested in accelerating breakthrough scientific discoveries to the clinic by building life science companies around new therapeutic technologies. Apollo Ventures focuses on assets with the potential to treat, prevent, or even reverse age-related diseases such as Alzheimer's, Heart Disease, Sarcopenia, Frailty, and Cancer, with the ultimate goal of increasing healthy human lifespan. Apollo invests in early stage companies, works with scientists and entrepreneurs to create new ventures, and engages in hypothesis-driven company building.

Visit website: http://apollo.vc/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

People at Apollo Ventures

Company Representative

Partner at Apollo Health Ventures

Company Representative

Co-Founder and Managing Director at Apollo Ventures

Company Representative

Co-Founder, Investment Director & Head of VentureLabs.

Company Representative

Co-Founder of Apollo Ventures

Apollo Ventures News

Apollo Health Ventures raised $180M fund to invest in longevity innovations

Endpoints News - 01-Dec-2021

Invests in early stage companies that target root causes of age-related diseases

Read more...

LEAF interviews Dr. Ole Mensching about Apollo Health Ventures' Moonshot Venture

Lifespan.io (LEAF) - 06-May-2020

VCs are starting to recognise ageing as a problem with a massive business opportunity

Read more...

Samsara secures more funding for cellular rejuvenation drug research

Lifespan.io (LEAF) - 06-Mar-2019

Drugs will need to work better than the free alternative - calorie restriction

Read more...

Cleara Biotech Joins the Race to Develop Senolytic Therapies

Lifespan.io (LEAF) - 09-Jul-2018

This therapy uses a modified FOXO4 to promote apoptosis in senescent cells

Read more...